| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $1.23 (Beat by $0.04) |
| EPS GAAP Actual | $1.23 (Beat by $0.04) |
| Revenue Actual | $1.4775B |
| Revenue Surprise | Beat by $1477.5M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.07965 |
| EPS GAAP Estimate | $1.07965 |
| Revenue Estimate | $1.435677864B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 5.19 | 22.21 | 5.13752 | 5.25084 | 1 |
| Dec 2027 | 5.56 | 20.73 | 5.50843 | 5.61514 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.26 | 0.13972 | 1.4775B | 8.56% | 69.99M |
| FQ2 2025 (Jun 2025) | 1.41 | 0.29305 | 1.4577B | 10.74% | 54.11M |
| FQ1 2025 (Mar 2025) | 1.5 | 1.5 | 1.4554B | 9.58% | 1455.4M |
| FQ4 2024 (Dec 2024) | 1.21 | 1.21 | 1.405B | 11.26% | 1405M |
| FQ3 2024 (Sep 2024) | 1.08 | 1.08 | 1.351B | 10.67% | 1351M |
| FQ2 2024 (Jun 2024) | 1.14 | 1.14 | 1.3012B | 8.77% | 1301.2M |
| FQ1 2024 (Mar 2024) | 1.13 | 1.13 | 1.316B | 11.82% | 1316M |
| FQ4 2023 (Dec 2023) | 0.88 | 0.88 | 1.2468B | 100% | 1246.8M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.07965
Consensus Revenue Estimates
1.435677864B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.515 | -- | 1.49923 | 1.54188 | 4 |
| FQ3 2027 (Sep 2027) | 1.33 | -- | 1.32251 | 1.34131 | 3 |
| FQ2 2027 (Jun 2027) | 1.4 | -- | 1.39212 | 1.4119 | 5 |
| FQ1 2027 (Mar 2027) | 1.45 | -- | 1.43369 | 1.46147 | 3 |
| FQ4 2026 (Oct 2026) | 1.19801 | -- | 1.18358 | 1.21109 | 3 |
| FQ3 2026 (Jul 2026) | 1.23621 | -1.92 | 1.22132 | 1.24971 | 5 |
| FQ2 2026 (Jun 2026) | 1.21954 | -15.62 | 1.20708 | 1.22607 | 5 |
| FQ1 2026 (Mar 2026) | 1.185 | -26.58 | 1.17691 | 1.20009 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.8B | -- | 1.78B | 1.82B | 5 |
| FQ3 2027 (Sep 2027) | 1.7B | -- | 1.69B | 1.71B | 3 |
| FQ2 2027 (Jun 2027) | 1.64B | -- | 1.64B | 1.65B | 3 |
| FQ1 2027 (Mar 2027) | 1.68B | -- | 1.67B | 1.69B | 3 |
| FQ4 2026 (Oct 2026) | 1.55B | -- | 1.54B | 1.57B | 4 |
| FQ3 2026 (Jul 2026) | 1.52B | 2.91 | 1.51B | 1.53B | 6 |
| FQ2 2026 (Jun 2026) | 1.52B | 3.96 | 1.51B | 1.52B | 6 |
| FQ1 2026 (Mar 2026) | 1.53B | 5.17 | 1.53B | 1.55B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.12028 | 1.26 | 0.13972 | 11.09% |
| FQ2 2025 (Jun 2025) | 1.11695 | 1.41 | 0.29305 | 20.78% |
| FQ1 2025 (Mar 2025) | 1.5 | 1.5 | 100% | |
| FQ4 2024 (Dec 2024) | 1.21 | 1.21 | 100% | |
| FQ3 2024 (Sep 2024) | 1.08 | 1.08 | 100% | |
| FQ2 2024 (Jun 2024) | 1.14 | 1.14 | 100% | |
| FQ1 2024 (Mar 2024) | 1.13 | 1.13 | 100% | |
| FQ4 2023 (Dec 2023) | 0.88 | 0.88 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.41B | $1.48B | $69.99M | 4.74% |
| FQ2 2025 (Jun 2025) | $1.4B | $1.46B | $54.11M | 3.71% |
| FQ1 2025 (Mar 2025) | $0B | $1.46B | $1455.4M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.41B | $1405M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.35B | $1351M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.3B | $1301.2M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.32B | $1316M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.25B | $1246.8M | 100% |